Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↵ to review claims



    Explore by Goal












     Quick Explanation


    Author Review (science-strength, evidence-based): Qiong Wu
    • Based on the raw-paper set provided, the author’s work spans mitogenomics, replication/epigenome biology, epitranscriptomics in cancer, and cell & tissue injury models, with generally strong mechanistic framing in the reviewed experimental studies (multiple designs include controls, genetic perturbations, and multi-omic readouts).
    • However, the “Qiong Wu” identity is ambiguous in the provided bibliometrics (multiple distinct “Wu” researchers plausibly conflated), which is a major risk to any author-wide conclusions.
    • Across the provided studies, key recurring rigor strengths are: explicit causal tests (knockouts/knockdowns/inhibitors), use of orthogonal assays (e.g., ChOR-seq/CUT&RUN + histone-mark readouts), and data-release claims where stated (e.g., GenBank/GEO for some studies).

    Selected evidence includes: complete mitogenome/phylogeny work (), replication-fork reversal mechanistic work (), epitranscriptomic clustering in gastric cancer (), and in vivo-to-mechanism cancer/biomedical studies such as GRHL2 EMT-MET scar regulation ().




     Long Explanation


    Author Review: Qiong Wu
    Epistemic caution: the provided author bibliometrics indicate multiple “Qiong Wu” matches (and an “Eric Q. Wu” match with very different topic emphasis). This creates a high risk that “Qiong Wu” work is name-collapsed across researchers, making author-level strength estimates uncertain. (This is inferred from the provided matches list; no unique disambiguation key was provided.)
    VISUAL 1 — Mitogenome features reported in the provided raw-data paper
    What this supports: the mitogenomics paper reports a complete mitochondrial genome, gene complement, base composition, and multi-method phylogenetic inference using concatenated PCGs and both Bayesian/ML approaches.
    VISUAL 2 — D2O-MRI inferred CSF production rates (compartment comparison)
    What this supports: a high-field dynamic D2O-MRI approach was used to estimate CSF production rates across ROIs and found larger estimated rates for extraventricular cistern compartments than for lateral ventricles in the provided summary.
    Skeptical note on inference limits: the provided limitations state that relaxation effects were not fully corrected and that D2O dose could transiently alter physiology; also ROI segmentation and single-compartment modeling could bias Q values.
    Evidence-based critique across the provided raw papers
    A) Experimental mechanistic biology (strongest evidence for scientific rigor)
    • Replication-fork reversal & epigenetic inheritance: the fork-reversal model is supported by “perturb-and-rescue” logic (fork-reversal deficiency vs PrimPol-mediated repriming generating ssDNA gaps, and downstream pathway dependence tests involving PARP1 and HMCES).
    • EMT–MET dynamics & scar formation: GRHL2 is manipulated in vivo and in keratinocyte EMT/MET models; the provided summary emphasizes linkage to Zeb1/miR-200 axis and scar readouts with histology/IHC/WB/RNA-seq. The study also explicitly flags limitations such as blinding not clearly reported and raw data not openly deposited (availability on request).
    • Cell-state engineering for survival under stress: glycogen engineering in MSCs targets starvation resistance, then extends to a bleomycin PF mouse model and uses RNA-seq enrichment to characterize remodeling. The study’s own limitations note short observation windows and reliance on a single PF model and viral delivery, which affects external validity and mechanistic specificity.
    B) Data-integration bioinformatics studies (useful but more vulnerable to inference leaps)
    • m6A regulator patterns in gastric cancer: multiple cohorts and immune-infiltration analyses are used, with an m6Ascore and associations to prognosis and immunotherapy cohorts. However, the provided summary explicitly notes that regulator expression is used as a proxy rather than direct mapping of m6A modifications; this introduces a surrogate-marker risk.
    C) Field/organism diversity: phylogenetics & comparative genomics
    • Complete mitochondrial genome phylogeny: methodological details are fairly standard and include alignment trimming, model selection, and both Bayesian and ML inference with multiple support metrics. The provided limitations focus on single-voucher sampling and limited intrafamily mitogenome data, both of which can distort finer phylogenetic relationships.
    Major blindspots & what could disprove the inferred “scientific strength”
    • Author-name disambiguation risk: the bibliometrics input suggests multiple “Wu” researchers may be conflated under “Qiong Wu”. If that conflation is wrong, the perceived strength could be artificially inflated or deflated.
    • Selection bias from the provided sample: this review critiques only the papers that appeared in the provided raw-data set; absence of other work (especially failures/negative results or low-rigor studies) can bias judgments.
    • Causality vs correlation varies by study type: mechanistic cell/animal work tends to include perturbations and rescues (stronger for causality), while transcriptomic clustering studies are more association-driven and rely on proxies (weaker for causal inference).
    • Model-dependence in imaging kinetics: the D2O-MRI CSF production inference depends on assumptions about replacement vs relaxation and a single-compartment model; results could change with improved correction/segmentation or alternative modeling.


    Feedback:    

    Updated: April 27, 2026

     Top Data Sources ExportMCP


     Analysis Wizard



    Compiles the mitogenome and CSF-D2O numeric summaries into machine-readable tables, then plots gene-counts and compartment production rates to compare reported signals across studies.



     Hypothesis Graveyard


    The apparent CSF-from-extraventricular cistern predominance is primarily an artifact of uncorrected D2O relaxation effects and ROI segmentation choices; if corrected kinetic modeling flips compartment contributions, the “non-choroid” conclusion collapses.


    m6Ascore prognostic value is driven mostly by general tumor inflammation/proliferation rather than m6A-regulator biology; if direct m6A mapping breaks the association, the biomarker’s mechanistic link fails.

     Science Art


    Author Review: Qiong Wu Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending